tibolone has been researched along with hrp 102 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, AE; Eilertsen, AL; Goeman, J; Kierulf, P; Mowinckel, MC; Olstad, OK; Ovstebø, R; Sandset, PM; Skretting, G | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Pinhal, MA; Pompei, LM; Silva, VF; Silveira, ER; Steiner, ML; Theodoro, TR | 1 |
| Cunha, EP; Fernandes, CE; Mader, AM; Petri, G; Pinhal, MA; Pompei, LM; Steiner, ML; Theodoro, TR | 1 |
| Graff-Iversen, S; Hofvind, S; Román, M; Sakshaug, S; Ursin, G; Vangen, S; Weiderpass, E | 1 |
1 trial(s) available for tibolone and hrp 102
| Article | Year |
|---|---|
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
Topics: Aged; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride | 2012 |
3 other study(ies) available for tibolone and hrp 102
| Article | Year |
|---|---|
Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?
Topics: Animals; Biomarkers; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Extracellular Matrix; Female; Glucuronidase; Heparan Sulfate Proteoglycans; Immunohistochemistry; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2015 |
Effects of estradiol, progestogens, and of tibolone on breast proliferation and apoptosis.
Topics: Animals; Apoptosis; Breast; Cell Proliferation; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Progestins; Random Allocation; Rats; Rats, Wistar | 2015 |
Postmenopausal hormone therapy and the risk of breast cancer in Norway.
Topics: Aged; Breast Neoplasms; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Risk | 2016 |